Selected article for: "laboratory testing and Sars CoV laboratory testing"
Author: Bailey, Dana; Konforte, Danijela; Barakauskas, Vilte E.; Yip, Paul M.; Kulasingam, Vathany; Abou El Hassan, Mohamed; Beach, Lori A.; Blasutig, Ivan M.; Catomeris, Peter; Dooley, Kent C.; Gong, Yanping; Kavsak, Peter; Randell, Edward W; Robinson, Jason L; Shaw, Julie; Taher, Jennifer; White-Al Habeeb, Nicole
Title: Canadian Society of Clinical Chemists (CSCC) Interim Consensus Guidance for Testing and Reporting of SARS-CoV-2 Serology
  • Cord-id: nw6xk4ai
  • Document date: 2020_10_6
    • ID: nw6xk4ai
    Snippet: Clinical laboratories across the world are working to validate and perform testing for SARS-CoV-2 antibodies. Herein, we present interim consensus guidance for Canadian clinical laboratories testing and reporting SARS-CoV-2 serology, with emphasis on the capabilities and limitations of these tests and recommendations for interpretative comments in an effort to achieve harmonized laboratory practices. The consensus document provides a broad overview of topics including sample type and contaminati
    Document: Clinical laboratories across the world are working to validate and perform testing for SARS-CoV-2 antibodies. Herein, we present interim consensus guidance for Canadian clinical laboratories testing and reporting SARS-CoV-2 serology, with emphasis on the capabilities and limitations of these tests and recommendations for interpretative comments in an effort to achieve harmonized laboratory practices. The consensus document provides a broad overview of topics including sample type and contamination risk; kinetics of antibody response to COVID-19 and the impact on serology testing; clinical utility of SARS-CoV-2 serology testing; clinical performance of commercial laboratory-based assays commonly deployed in North America; recommendations for interim reporting; utility of SARS-CoV-2 antibody testing for pediatric patients; and utility of point-of-care testing. The information is based on the current literature and is subject to change as additional information becomes available.

    Search related documents:
    Co phrase search for related documents
    • accuracy precision and acute diagnosis: 1, 2
    • accuracy precision and acute infection: 1, 2, 3, 4, 5, 6, 7, 8
    • accuracy precision and acute infection disease: 1, 2
    • accuracy precision and acute sars infection: 1, 2, 3, 4
    • accuracy precision and additional information: 1
    • accuracy precision and low throughput: 1, 2
    • accurate basis and active infection: 1
    • accurate basis and active infection diagnosis: 1
    • accurate basis and additional information: 1
    • active infection and acute diagnosis: 1, 2, 3
    • active infection and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
    • active infection and acute infection disease: 1, 2, 3, 4, 5
    • active infection and acute sars infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • active infection and local guideline: 1
    • active infection and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active infection diagnosis and low prevalence: 1